Clinical trial NCT03317925 - References

Renal Transplant — Renal Transplant Injury and the Renin-Angiotensin System in Kids (RETASK)

Citation(s)

•   Ahmed AK, El Nahas AM, Johnson TS
  Changes in matrix metalloproteinases and their inhibitors in kidney transplant recipients. Exp Clin Transplant. 2012 Aug;10(4):332-43.
•   Arbeiter K, Pichler A, Stemberger R, Mueller T, Ruffingshofer D, Vargha R, Balzar E, Aufricht C
  ACE inhibition in the treatment of children after renal transplantation. Pediatr Nephrol. 2004 Feb;19(2):222-6. Epub 2003 Dec 13.
•   Brosnihan KB, Neves LA, Joyner J, Averill DB, Chappell MC, Sarao R, Penninger J, Ferrario CM
  Enhanced renal immunocytochemical expression of ANG-(1-7) and ACE2 during pregnancy. Hypertension. 2003 Oct;42(4):749-53. Epub 2003 Jul 21.
•   Castoldi G, di Gioia CR, Travaglini C, Busca G, Redaelli S, Bombardi C, Stella A
  Angiotensin II increases tissue-specific inhibitor of metalloproteinase-2 expression in rat aortic smooth muscle cells in vivo: evidence of a pressure-independent effect. Clin Exp Pharmacol Physiol. 2007 Mar;34(3):205-9.
•   Clark MA, Tallant EA, Diz DI
  Downregulation of the AT1A receptor by pharmacologic concentrations of Angiotensin-(1-7). J Cardiovasc Pharmacol. 2001 Apr;37(4):437-48.
•   Dai B, David V, Martin A, Huang J, Li H, Jiao Y, Gu W, Quarles LD
  A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model. PLoS One. 2012;7(9):e44161. doi: 10.1371/journal.pone.0044161. Epub 2012 Sep 6.
•   Dilauro M, Burns KD
  Angiotensin-(1-7) and its effects in the kidney. ScientificWorldJournal. 2009 Jun 30;9:522-35. doi: 10.1100/tsw.2009.70. Review.
•   Dong J, Wong SL, Lau CW, Lee HK, Ng CF, Zhang L, Yao X, Chen ZY, Vanhoutte PM, Huang Y
  Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress. Eur Heart J. 2012 Dec;33(23):2980-90. doi: 10.1093/eurheartj/ehr459. Epub 2012 Jan 19.
•   Ejaz AA, Kambhampati G, Ejaz NI, Dass B, Lapsia V, Arif AA, Asmar A, Shimada M, Alsabbagh MM, Aiyer R, Johnson RJ
  Post-operative serum uric acid and acute kidney injury. J Nephrol. 2012 Jul-Aug;25(4):497-505. doi: 10.5301/jn.5000173.
•   el-Agroudy AE, Hassan NA, Foda MA, Ismail AM, el-Sawy EA, Mousa O, Ghoneim MA
  Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients. Am J Nephrol. 2003 Sep-Oct;23(5):300-6. Epub 2003 Aug 6.
•   Feig DI
  Hyperuricemia and hypertension. Adv Chronic Kidney Dis. 2012 Nov;19(6):377-85. doi: 10.1053/j.ackd.2012.05.009.
•   Ferrario CM
  ACE2: more of Ang-(1-7) or less Ang II? Curr Opin Nephrol Hypertens. 2011 Jan;20(1):1-6. doi: 10.1097/MNH.0b013e3283406f57. Review.
•   Furness PN, Taub N, Assmann KJ, Banfi G, Cosyns JP, Dorman AM, Hill CM, Kapper SK, Waldherr R, Laurinavicius A, Marcussen N, Martins AP, Nogueira M, Regele H, Seron D, Carrera M, Sund S, Taskinen EI, Paavonen T, Tihomirova T, Rosenthal R
  International variation in histologic grading is large, and persistent feedback does not improve reproducibility. Am J Surg Pathol. 2003 Jun;27(6):805-10.
•   Geara AS, Azzi J, Jurewicz M, Abdi R
  The renin-angiotensin system: an old, newly discovered player in immunoregulation. Transplant Rev (Orlando). 2009 Jul;23(3):151-8. doi: 10.1016/j.trre.2009.04.002. Review.
•   Grimm PC, Nickerson P, Gough J, McKenna R, Stern E, Jeffery J, Rush DN
  Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function. J Am Soc Nephrol. 2003 Jun;14(6):1662-8.
•   Halawa A
  The early diagnosis of acute renal graft dysfunction: a challenge we face. The role of novel biomarkers. Ann Transplant. 2011 Jan-Mar;16(1):90-8. Review.
•   Hall IE, Yarlagadda SG, Coca SG, Wang Z, Doshi M, Devarajan P, Han WK, Marcus RJ, Parikh CR
  IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol. 2010 Jan;21(1):189-97. doi: 10.1681/ASN.2009030264. Epub 2009 Sep 17.
•   Haririan A, Metireddy M, Cangro C, Nogueira JM, Rasetto F, Cooper M, Klassen DK, Weir MR
  Association of serum uric acid with graft survival after kidney transplantation: a time-varying analysis. Am J Transplant. 2011 Sep;11(9):1943-50. doi: 10.1111/j.1600-6143.2011.03613.x. Epub 2011 Aug 3.
•   Heringer-Walther S, Eckert K, Schumacher SM, Uharek L, Wulf-Goldenberg A, Gembardt F, Fichtner I, Schultheiss HP, Rodgers K, Walther T
  Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo. Haematologica. 2009 Jun;94(6):857-60. doi: 10.3324/haematol.2008.000034. Epub 2009 Apr 18.
•   Iwai M, Horiuchi M
  Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens Res. 2009 Jul;32(7):533-6. doi: 10.1038/hr.2009.74. Epub 2009 May 22. Review.
•   Jurewicz M, McDermott DH, Sechler JM, Tinckam K, Takakura A, Carpenter CB, Milford E, Abdi R
  Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation. J Am Soc Nephrol. 2007 Apr;18(4):1093-102. Epub 2007 Feb 28.
•   Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, Johnson RJ
  Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003 Jun;41(6):1287-93. Epub 2003 May 12.
•   Koka V, Huang XR, Chung AC, Wang W, Truong LD, Lan HY
  Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway. Am J Pathol. 2008 May;172(5):1174-83. doi: 10.2353/ajpath.2008.070762. Epub 2008 Apr 10.
•   Ling XB, Sigdel TK, Lau K, Ying L, Lau I, Schilling J, Sarwal MM
  Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. J Am Soc Nephrol. 2010 Apr;21(4):646-53. doi: 10.1681/ASN.2009080876. Epub 2010 Feb 11.
•   Luque M, Martin P, Martell N, Fernandez C, Brosnihan KB, Ferrario CM
  Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension. J Hypertens. 1996 Jun;14(6):799-805.
•   Lutz J, Yao Y, Song E, Antus B, Hamar P, Liu S, Heemann U
  Inhibition of matrix metalloproteinases during chronic allograft nephropathy in rats. Transplantation. 2005 Mar 27;79(6):655-61.
•   Mazanowska O, Kaminska D, Krajewska M, Zabinska M, Kopec W, Boratynska M, Chudoba P, Patrzalek D, Klinger M
  Imbalance of metallaproteinase/tissue inhibitors of metalloproteinase system in renal transplant recipients with chronic allograft injury. Transplant Proc. 2011 Oct;43(8):3000-3. doi: 10.1016/j.transproceed.2011.08.012.
•   Miyake-Ogawa C, Miyazaki M, Abe K, Harada T, Ozono Y, Sakai H, Koji T, Kohno S
  Tissue-specific expression of renin-angiotensin system components in IgA nephropathy. Am J Nephrol. 2005 Jan-Feb;25(1):1-12. Epub 2005 Jan 7.
•   Mizuiri S, Aoki T, Hemmi H, Arita M, Sakai K, Aikawa A
  Urinary angiotensin-converting enzyme 2 in patients with CKD. Nephrology (Carlton). 2011 Aug;16(6):567-72. doi: 10.1111/j.1440-1797.2011.01467.x.
•   Mizuiri S, Hemmi H, Arita M, Aoki T, Ohashi Y, Miyagi M, Sakai K, Shibuya K, Hase H, Aikawa A
  Increased ACE and decreased ACE2 expression in kidneys from patients with IgA nephropathy. Nephron Clin Pract. 2011;117(1):c57-66. doi: 10.1159/000319648. Epub 2010 Aug 4.
•   Mizuiri S, Hemmi H, Arita M, Ohashi Y, Tanaka Y, Miyagi M, Sakai K, Ishikawa Y, Shibuya K, Hase H, Aikawa A
  Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls. Am J Kidney Dis. 2008 Apr;51(4):613-23. doi: 10.1053/j.ajkd.2007.11.022. Epub 2008 Mar 4.
•   Moon JY
  ACE2 and Angiotensin-(1-7) in Hypertensive Renal Disease. Electrolyte Blood Press. 2011 Dec;9(2):41-4. doi: 10.5049/EBP.2011.9.2.41. Epub 2011 Dec 31.
•   Numakura K, Satoh S, Tsuchiya N, Saito M, Maita S, Obara T, Tsuruta H, Inoue T, Narita S, Horikawa Y, Kagaya H, Miura M, Habuchi T
  Hyperuricemia at 1 year after renal transplantation, its prevalence, associated factors, and graft survival. Transplantation. 2012 Jul 27;94(2):145-51. doi: 10.1097/TP.0b013e318254391b.
•   Oudit GY, Herzenberg AM, Kassiri Z, Wong D, Reich H, Khokha R, Crackower MA, Backx PH, Penninger JM, Scholey JW
  Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Pathol. 2006 Jun;168(6):1808-20.
•   Pan CH, Wen CH, Lin CS
  Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes. Exp Physiol. 2008 May;93(5):599-612. doi: 10.1113/expphysiol.2007.041830. Epub 2008 Feb 22.
•   Rüster C, Wolf G
  Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol. 2006 Nov;17(11):2985-91. Epub 2006 Oct 11. Review.
•   Santos RA, Ferreira AJ, Pinheiro SV, Sampaio WO, Touyz R, Campagnole-Santos MJ
  Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs. Expert Opin Investig Drugs. 2005 Aug;14(8):1019-31. Review.
•   Santos RA, Ferreira AJ, Simões E Silva AC
  Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol. 2008 May;93(5):519-27. doi: 10.1113/expphysiol.2008.042002. Epub 2008 Feb 29. Review.
•   Schaub S, Mayr M, Hönger G, Bestland J, Steiger J, Regeniter A, Mihatsch MJ, Wilkins JA, Rush D, Nickerson P
  Detection of subclinical tubular injury after renal transplantation: comparison of urine protein analysis with allograft histopathology. Transplantation. 2007 Jul 15;84(1):104-12.
•   Shah PR, Kute VB, Saboo DS, Goplani KR, Gumber MR, Vanikar AV, Patel HV, Trivedi HL
  Safety and efficacy of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in chronic allograft injury. Saudi J Kidney Dis Transpl. 2011 Nov;22(6):1128-32.
•   Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, Cosio F, David DS, Drachenberg C, Einecke G, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, Mannon RB, Mihatsch M, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Roberts I, Seron D, Smith RN, Valente M
  Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant. 2008 Apr;8(4):753-60. doi: 10.1111/j.1600-6143.2008.02159.x. Epub 2008 Feb 19.
•   Su Z, Zimpelmann J, Burns KD
  Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int. 2006 Jun;69(12):2212-8. Epub 2006 May 3.
•   Szabo A, Lutz J, Schleimer K, Antus B, Hamar P, Philipp T, Heemann U
  Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat. Kidney Int. 2000 Mar;57(3):982-91.
•   Tylicki L, Biedunkiewicz B, Chamienia A, Wojnarowski K, Zdrojewski Z, Aleksandrowicz E, Lysiak-Szydlowska W, Rutkowski B
  Renal allograft protection with angiotensin II type 1 receptor antagonists. Am J Transplant. 2007 Jan;7(1):243-8.
•   Xiao F, Hiremath S, Knoll G, Zimpelmann J, Srivaratharajah K, Jadhav D, Fergusson D, Kennedy CR, Burns KD
  Increased urinary angiotensin-converting enzyme 2 in renal transplant patients with diabetes. PLoS One. 2012;7(5):e37649. doi: 10.1371/journal.pone.0037649. Epub 2012 May 22.

Renal Transplant Injury and the Renin-Angiotensin System in Kids (RETASK)

Details for clinical trial NCT03317925